Concepedia

Nisha Revirajan

NR

8

Publications

361

Citations

8

H-Index

2014

Active since

Affiliations

University of California, San Francisco(Current)

Johns Hopkins University

Yale University

Oregon Health & Science University

Nisha Revirajan is an author at University of California, San Francisco specializing in medicine, neurology, and multiple sclerosis.

Top concepts

Publications per year

2014–2021

8

Publications

8

Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial

Bardia Nourbakhsh, Nisha Revirajan, Bridget Morris et al. · The Lancet Neurology · 2020 · 167 citations · Full text

, , +7

Multiple sclerosis patients have a diminished serologic response to vitamin D supplementation compared to healthy controls

Pavan Bhargava, Sonya Steele, Emmanuelle Waubant et al. · Multiple Sclerosis Journal · 2015 · 61 citations · Full text

A randomized controlled phase II trial of riluzole in early multiple sclerosis

Emmanuelle Waubant, Amir‐Hadi Maghzi, Nisha Revirajan et al. · Annals of Clinical and Translational Neurology · 2014 · 36 citations · Full text

Magnetic resonance imaging correlates of clinical outcomes in early multiple sclerosis

Amir‐Hadi Maghzi, Nisha Revirajan, Laura Julián et al. · Multiple Sclerosis and Related Disorders · 2014 · 33 citations

, , +8

Treatment of fatigue with methylphenidate, modafinil and amantadine in multiple sclerosis (TRIUMPHANT-MS): Study design for a pragmatic, randomized, double-blind, crossover clinical trial

Bardia Nourbakhsh, Nisha Revirajan, Emmanuelle Waubant · Contemporary Clinical Trials · 2017 · 22 citations

, , +6

Rows per page

1–5 of 8